Is Hantech BioTechnology Co stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Hantech BioTechnology Co pays dividends. Last time was Friday 5th of July 2024 where the investors holding the stock on Thursday 6th of June 2024 were paid TWD1 per share. Over the last 2 times between 2023 and 2024, Hantech BioTechnology Co has paid TWD2.15 with an average of TWD1.08 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Hantech BioTechnology Co 10 years ago, but if you had invested on Thursday 29th of September 2022 when the price was TWD36.61, you would have made a profit of TWD55.09 per share or 150.48%
Yes, the average daily trading liquidity for Hantech BioTechnology Co is TWD124 184 thousand. You should therefore be able to get in and out of your positions relatively fast.
Hantech BioTechnology Co has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.63, the company's ability to pay off the debt is good. Hantech BioTechnology Co has a very good net profit margin of 22.24% and should have very high tolerances against inflation.
We have calculated the inflation risk for Hantech BioTechnology Co to be low [0.15 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.